Terms: = Germ cell tumor AND FGFR1OP, FOP, 11116, ENSG00000213066 AND Treatment
8 results:
1. Circ
Li J; Ma J; Huang S; Li J; Zhou L; Sun J; Chen L
Mol Cell Biol; 2023; 43(7):354-369. PubMed ID: 37427890
[TBL] [Abstract] [Full Text] [Related]
2. miR-363-3p induces EMT via the Wnt/β-catenin pathway in glioma cells by targeting CELF2.
Fan B; Su B; Song G; Liu X; Yan Z; Wang S; Hu F; Yang J
J Cell Mol Med; 2021 Nov; 25(22):10418-10429. PubMed ID: 34636136
[TBL] [Abstract] [Full Text] [Related]
3. ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma.
Sekimata K; Sato T; Sakai N
Chem Pharm Bull (Tokyo); 2020; 68(3):194-200. PubMed ID: 32115526
[TBL] [Abstract] [Full Text] [Related]
4. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract] [Full Text] [Related]
5. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
[TBL] [Abstract] [Full Text] [Related]
6. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma cells.
Huang W; Zhang C; Cui M; Niu J; Ding W
Anticancer Res; 2017 Aug; 37(8):4285-4294. PubMed ID: 28739720
[TBL] [Abstract] [Full Text] [Related]
8. Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.
Pacifici M; Shore EM
Cytokine Growth Factor Rev; 2016 Feb; 27():93-104. PubMed ID: 26776312
[TBL] [Abstract] [Full Text] [Related]
